Both in Pharmaceuticals
Relmada Therapeutics vs Indaptus Therapeutics
Over the past year RLMD returned +58.4% and INDP returned −4.0%; their daily moves had a correlation of 0.04.
RLMD +58.4% INDP −4.0%Growth of $1, one year, split-adjusted
| Metric | RLMD | INDP |
|---|---|---|
| Price | $3.58 | $3.09 |
| Market cap | $381.9M | $411.7M |
| Today | +4.07% | −7.49% |
| 1 month | −2.2% | +45.8% |
| 6 months | −53.1% | +44.4% |
| Year to date | −25.9% | +6.2% |
| 1 year | +46.1% | −7.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $217.7M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 191.8% |
| Short % of float | 14.0% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).